339 related articles for article (PubMed ID: 27498701)
1. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury.
Liu Y; Zhao C; Xiao J; Liu L; Zhang M; Wang C; Wu G; Zheng MH; Xu LM; Chen YP; Mohammadi M; Chen SY; Cave M; McClain C; Li X; Feng W
Sci Rep; 2016 Aug; 6():31026. PubMed ID: 27498701
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
[TBL] [Abstract][Full Text] [Related]
3. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
[TBL] [Abstract][Full Text] [Related]
5. FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice.
Zhao C; Liu Y; Xiao J; Liu L; Chen S; Mohammadi M; McClain CJ; Li X; Feng W
J Lipid Res; 2015 Aug; 56(8):1481-91. PubMed ID: 26092866
[TBL] [Abstract][Full Text] [Related]
6. ZFP36L1 Regulates Fgf21 mRNA Turnover and Modulates Alcoholic Hepatic Steatosis and Inflammation in Mice.
Bathula CS; Chen J; Kumar R; Blackshear PJ; Saini Y; Patial S
Am J Pathol; 2022 Feb; 192(2):208-225. PubMed ID: 34774847
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.
Desai BN; Singhal G; Watanabe M; Stevanovic D; Lundasen T; Fisher FM; Mather ML; Vardeh HG; Douris N; Adams AC; Nasser IA; FitzGerald GA; Flier JS; Skarke C; Maratos-Flier E
Mol Metab; 2017 Nov; 6(11):1395-1406. PubMed ID: 29107287
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
Zhao C; Liu L; Liu Q; Li F; Zhang L; Zhu F; Shao T; Barve S; Chen Y; Li X; McClain CJ; Feng W
Mol Metab; 2019 Nov; 29():145-157. PubMed ID: 31668386
[TBL] [Abstract][Full Text] [Related]
9. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
10. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
[TBL] [Abstract][Full Text] [Related]
11. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
Weng HC; Lu XY; Xu YP; Wang YH; Wang D; Feng YL; Chi Z; Yan XQ; Lu CS; Wang HW
Mol Med; 2021 Nov; 27(1):147. PubMed ID: 34773993
[TBL] [Abstract][Full Text] [Related]
13. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
14. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
15. A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease.
Woolsey SJ; Beaton MD; Mansell SE; Leon-Ponte M; Yu J; Pin CL; Adams PC; Kim RB; Tirona RG
Mol Pharmacol; 2016 Oct; 90(4):437-46. PubMed ID: 27482056
[TBL] [Abstract][Full Text] [Related]
16. Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver.
Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Songserm T; Saengsirisuwan V
Am J Physiol Endocrinol Metab; 2017 Aug; 313(2):E203-E212. PubMed ID: 28559436
[TBL] [Abstract][Full Text] [Related]
17. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
18. Role of Fn14 in acute alcoholic steatohepatitis in mice.
Karaca G; Xie G; Moylan C; Swiderska-Syn M; Guy CD; Krüger L; Machado MV; Choi SS; Michelotti GA; Burkly LC; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G325-34. PubMed ID: 25524063
[TBL] [Abstract][Full Text] [Related]
19. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.
Chen X; Ward SC; Cederbaum AI; Xiong H; Lu Y
Toxicology; 2017 Mar; 379():12-21. PubMed ID: 28131861
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.
Zarei M; Pujol E; Quesada-López T; Villarroya F; Barroso E; Vázquez S; Pizarro-Delgado J; Palomer X; Vázquez-Carrera M
Br J Pharmacol; 2019 Jul; 176(13):2292-2305. PubMed ID: 30927369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]